Roche Investor Day 2010
Thursday 18 March 2010
Webcast
Listen to the recorded webcast with synchronized slides.
Your browser does not support Adobe Flash
The Adobe Flash player is needed, to watch and listen to slideshows
The original content can be found here: http://www.roche.com/streaming/smil/irp100318p1.smil
Roche Investor Day 2010
-
Part 1 - Diversity of approaches to innovation
(136:45)
See agenda below for more details
F. Hoffmann-La Roche Ltd.
-
Part 2 - Sustainable growth
(85:41)
See agenda below for more details
F. Hoffmann-La Roche Ltd.
-
Part 3 - New growth opportunities
(77:28)
See agenda below for more details
F. Hoffmann-La Roche Ltd.
Agenda:
“Diversity of approaches to innovation”
- Introduction: Severin Schwan, CEO Roche Group
- Translating science into innovative therapies: Richard Scheller, Global Head gRED
- Harnessing therapeutic modalities: Jean-Jacques Garaud, Global Head pRED
- Roche Partnering, enriching our portfolio: Dan Zabrowski, Global Head Pharma Partnering
- Diagnostics and personalised healthcare: Daniel O’Day, COO Diagnostics Division
- Q&A
“Sustainable growth”
- Sustainable growth through innovation: Pascal Soriot, COO Pharma Medicines
- Biosimilar: market dynamics and the Roche portfolio: Mike Doherty, Global Head Regulatory, Pharma
- Near-term opportunities: David Löw, Head Global Product Strategy, Pharma
- Q&A
“New growth opportunities”
- New late-stage opportunities: Hal Barron, Head Product Development & CMO, Pharma
- “Roche unedited” - Q&A with all speakers